Literature DB >> 27220409

Allocyclinones, hyperchlorinated angucyclinones from Actinoallomurus.

Joao C S Cruz1,2, Sonia I Maffioli2,3, Alice Bernasconi3, Cristina Brunati3, Eleonora Gaspari3, Margherita Sosio1,3, Elizabeth Wellington2, Stefano Donadio1,3.   

Abstract

A screening program on a limited number of strains belonging to the Actinoallomurus genus yielded a series of new angucyclinones. NMR and MS analyses established that these compounds are characterized by an unusual lactone ring and present up to four halogens per molecule, with one congener representing the first natural product containing a trichloromethyl substitution on an aromatic system. Remarkably, this family of metabolites seems to be produced by phylogenetically distinct Actinoallomurus isolates. Because of the unique structural features and wide distribution among Actinoallomurus, we have designated these angucyclinones as allocyclinones. Allocyclinones possess interesting activity against different Gram-positive bacteria, including antibiotic-resistant strains, with antibacterial potency increasing with the number of chlorine substituents. The tetrachlorinated compound is the most abundant congener in the allocyclinone complex.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27220409     DOI: 10.1038/ja.2016.62

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  20 in total

1.  Barbamide, a chlorinated metabolite with molluscicidal activity from the Caribbean cyanobacterium Lyngbya majuscula.

Authors:  J Orjala; W H Gerwick
Journal:  J Nat Prod       Date:  1996-04       Impact factor: 4.050

2.  Antibiotics: a new hope.

Authors:  Gerard D Wright
Journal:  Chem Biol       Date:  2012-01-27

Review 3.  Thoughts and facts about antibiotics: where we are now and where we are heading.

Authors:  János Bérdy
Journal:  J Antibiot (Tokyo)       Date:  2012-04-18       Impact factor: 2.649

Review 4.  Natural products as sources of new drugs over the 30 years from 1981 to 2010.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2012-02-08       Impact factor: 4.050

5.  New PCR primers for the selective amplification of 16S rDNA from different groups of actinomycetes.

Authors:  Paolo Monciardini; Margherita Sosio; Linda Cavaletti; Claudia Chiocchini; Stefano Donadio
Journal:  FEMS Microbiol Ecol       Date:  2002-12-01       Impact factor: 4.194

6.  Actinoallolides A-E, new anti-trypanosomal macrolides, produced by an endophytic actinomycete, Actinoallomurus fulvus MK10-036.

Authors:  Yuki Inahashi; Masato Iwatsuki; Aki Ishiyama; Atsuko Matsumoto; Tomoyasu Hirose; Jun Oshita; Toshiaki Sunazuka; Watanalai Panbangred; Yoko Takahashi; Marcel Kaiser; Kazuhiko Otoguro; Satoshi Ōmura
Journal:  Org Lett       Date:  2015-01-30       Impact factor: 6.005

7.  The genus Actinoallomurus and some of its metabolites.

Authors:  Roberta Pozzi; Matteo Simone; Carlo Mazzetti; Sonia Maffioli; Paolo Monciardini; Linda Cavaletti; Ruggiero Bamonte; Margherita Sosio; Stefano Donadio
Journal:  J Antibiot (Tokyo)       Date:  2010-12-01       Impact factor: 2.649

8.  A new angucycline and a new butenolide isolated from lichen-derived Streptomyces spp.

Authors:  Keiichiro Motohashi; Motoki Takagi; Hideki Yamamura; Masayuki Hayakawa; Kazuo Shin-ya
Journal:  J Antibiot (Tokyo)       Date:  2010-07-28       Impact factor: 2.649

9.  New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.

Authors:  Imanol Peña; M Pilar Manzano; Juan Cantizani; Albane Kessler; Julio Alonso-Padilla; Ana I Bardera; Emilio Alvarez; Gonzalo Colmenarejo; Ignacio Cotillo; Irene Roquero; Francisco de Dios-Anton; Vanessa Barroso; Ana Rodriguez; David W Gray; Miguel Navarro; Vinod Kumar; Alexander Sherstnev; David H Drewry; James R Brown; Jose M Fiandor; J Julio Martin
Journal:  Sci Rep       Date:  2015-03-05       Impact factor: 4.379

Review 10.  Discovering new bioactive molecules from microbial sources.

Authors:  Paolo Monciardini; Marianna Iorio; Sonia Maffioli; Margherita Sosio; Stefano Donadio
Journal:  Microb Biotechnol       Date:  2014-03-24       Impact factor: 5.813

View more
  6 in total

1.  Colibrimycins, Novel Halogenated Hybrid Polyketide Synthase-Nonribosomal Peptide Synthetase (PKS-NRPS) Compounds Produced by Streptomyces sp. Strain CS147.

Authors:  Laura Prado-Alonso; Ignacio Pérez-Victoria; Mónica G Malmierca; Ignacio Montero; Elisa Rioja-Blanco; Jesús Martín; Fernando Reyes; Carmen Méndez; José A Salas; Carlos Olano
Journal:  Appl Environ Microbiol       Date:  2021-10-20       Impact factor: 5.005

2.  Allopeptimicins: unique antibacterial metabolites generated by hybrid PKS-NRPS, with original self-defense mechanism in Actinoallomurus.

Authors:  Marianna Iorio; Andrea Gentile; Cristina Brunati; Arianna Tocchetti; Paolo Landini; Sonia Ilaria Maffioli; Stefano Donadio; Margherita Sosio
Journal:  RSC Adv       Date:  2022-06-06       Impact factor: 4.036

3.  Nocardiopsistins A-C: New angucyclines with anti-MRSA activity isolated from a marine sponge-derived Nocardiopsis sp. HB-J378.

Authors:  Dongbo Xu; Keshav K Nepal; Jing Chen; Dedra Harmody; Haining Zhu; Peter J McCarthy; Amy E Wright; Guojun Wang
Journal:  Synth Syst Biotechnol       Date:  2018-11-02

Review 4.  Promising bioactive compounds from the marine environment and their potential effects on various diseases.

Authors:  Akash Karthikeyan; Abey Joseph; Baiju G Nair
Journal:  J Genet Eng Biotechnol       Date:  2022-01-26

5.  Novel Polyethers from Screening Actinoallomurus spp.

Authors:  Marianna Iorio; Arianna Tocchetti; Joao Carlos Santos Cruz; Giancarlo Del Gatto; Cristina Brunati; Sonia Ilaria Maffioli; Margherita Sosio; Stefano Donadio
Journal:  Antibiotics (Basel)       Date:  2018-06-14

Review 6.  Secondary Metabolites of Actinomycetes and their Antibacterial, Antifungal and Antiviral Properties.

Authors:  Katarzyna Jakubiec-Krzesniak; Aleksandra Rajnisz-Mateusiak; Adam Guspiel; Joanna Ziemska; Jolanta Solecka
Journal:  Pol J Microbiol       Date:  2018
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.